215 related articles for article (PubMed ID: 1722549)
1. Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation.
Gadish M; Kletter Y; Flidel O; Nagler A; Slavin S; Fabian I
Leuk Res; 1991; 15(12):1175-82. PubMed ID: 1722549
[TBL] [Abstract][Full Text] [Related]
2. Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation.
Fabian I; Kletter Y; Bleiberg I; Gadish M; Naparsteck E; Slavin S
Exp Hematol; 1991 Oct; 19(9):868-73. PubMed ID: 1716591
[TBL] [Abstract][Full Text] [Related]
3. In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity.
Wiltschke C; Krainer M; Nanut M; Wagner A; Linkesch W; Zielinski CC
J Interferon Cytokine Res; 1995 Mar; 15(3):249-53. PubMed ID: 7584671
[TBL] [Abstract][Full Text] [Related]
4. Effects of human interleukin 3, macrophage and granulocyte-macrophage colony-stimulating factor on monocyte function following autologous bone marrow transplantation.
Fabian I; Shapira E; Gadish M; Kletter Y; Nagler A; Flidel O; Slavin S
Leuk Res; 1992; 16(6-7):703-9. PubMed ID: 1321933
[TBL] [Abstract][Full Text] [Related]
5. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
Nemunaitis J; Cox J; Meyer W; Courtney A; Hanson T; Green-Weaver C; Agosti J
Am J Clin Oncol; 1998 Jun; 21(3):308-12. PubMed ID: 9626806
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of granulocyte- and granulocyte-macrophage colony-stimulating factors (G- and GM-CSF) on neutrophil adhesion in vitro and in vivo.
Yong KL; Linch DC
Eur J Haematol; 1992 Nov; 49(5):251-9. PubMed ID: 1282108
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
[TBL] [Abstract][Full Text] [Related]
8. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trial.
Khwaja A; Linch DC; Goldstone AH; Chopra R; Marcus RE; Wimperis JZ; Russell NH; Haynes AP; Milligan DW; Leyland MJ
Br J Haematol; 1992 Oct; 82(2):317-23. PubMed ID: 1419813
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human granulocyte colony-stimulating factor on neutrophil function in vitro and in vivo following chemotherapy and autologous bone marrow transplantation.
Humphreys JM; Rugman FP; Davies JM; Mimnagh P; Hart CA; Edwards SW
J Clin Lab Immunol; 1991 Feb; 34(2):55-61. PubMed ID: 1725883
[TBL] [Abstract][Full Text] [Related]
12. Effect of granulocyte-macrophage colony-stimulating factor on superoxide production in cytoplasts and intact human neutrophils: role of protein kinase and G-proteins.
Mege JL; Gomez-Cambronero J; Molski TF; Becker EL; Sha'afi RI
J Leukoc Biol; 1989 Aug; 46(2):161-8. PubMed ID: 2545809
[TBL] [Abstract][Full Text] [Related]
13. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M
Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of infectious disease in patients who received recombinant human granulocyte-macrophage colony-stimulating factor versus patients not receiving a cytokine who underwent autologous bone marrow transplantation for treatment of lymphoid cancer.
Nemunaitis J; Buckner CD; Dorsey KS; Willis D; Meyer W; Appelbaum F
Am J Clin Oncol; 1998 Aug; 21(4):341-6. PubMed ID: 9708630
[TBL] [Abstract][Full Text] [Related]
15. Antibody to Mol abrogates the increase in neutrophil phagocytosis and degranulation induced by granulocyte-macrophage colony-stimulating factor.
Kletter Y; Bleiberg I; Golde DW; Fabian I
Eur J Haematol; 1989 Nov; 43(5):389-96. PubMed ID: 2482194
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
Advani R; Chao NJ; Horning SJ; Blume KG; Ahn DK; Lamborn KR; Fleming NC; Bonnem EM; Greenberg PL
Ann Intern Med; 1992 Feb; 116(3):183-9. PubMed ID: 1345803
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms.
Balazovich KJ; Almeida HI; Boxer LA
J Lab Clin Med; 1991 Dec; 118(6):576-84. PubMed ID: 1720802
[TBL] [Abstract][Full Text] [Related]
18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
Vose JM; Pandite AN; Beveridge RA; Geller RB; Schuster MW; Anderson JE; LeMaistre CF; Ahmed T; Granena A; Keating A; Fernandez Ranada JM; Stiff PJ; Tabbara I; Longo W; Copelan EA; Nichols C; Smith A; Topolsky DL; Bierman PJ; Lebsack ME; Lange M; Garrison L
J Clin Oncol; 1997 Apr; 15(4):1617-23. PubMed ID: 9193361
[TBL] [Abstract][Full Text] [Related]
20. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
